These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26947511)

  • 1. Strategies toward optimization of the metabolism of a series of serotonin-4 partial agonists: investigation of azetidines as piperidine isosteres.
    Obach RS; LaChapelle EA; Brodney MA; Vanase-Frawley M; Kauffman GW; Sawant-Basak A
    Xenobiotica; 2016 Dec; 46(12):1112-1121. PubMed ID: 26947511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of a serotonin-4 receptor partial agonist 4-{4-[4-tetrahydrofuran-3-yloxy)-benzo[d]isoxazol-3-yloxymethyl]-piperidin-1-ylmethyl}-tetrahydropyran-4-ol (TBPT): identification of an unusual pharmacologically active cyclized oxazolidine metabolite in human.
    Sawant-Basak A; Coffman KJ; Walker GS; Ryder TF; Tseng E; Miller E; Lee C; Vanase-Frawley MA; Wong JW; Brodney MA; Rapp T; Obach RS
    J Pharm Sci; 2013 Sep; 102(9):3277-93. PubMed ID: 23589342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of Circulating Drug Metabolite Exposure in Human Using In Vitro Data and Physiologically Based Pharmacokinetic Modeling: Example of a High Metabolite/Parent Drug Ratio.
    Obach RS; Lin J; Kimoto E; Duvvuri S; Nicholas T; Kadar EP; Tremaine LM; Sawant-Basak A
    Drug Metab Dispos; 2018 Feb; 46(2):89-99. PubMed ID: 29150544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigating a Bioactivation Liability with an Azetidine-Based Inhibitor of Diacylglycerol Acyltransferase 2 (DGAT2) En Route to the Discovery of the Clinical Candidate Ervogastat.
    Sharma R; Dowling MS; Futatsugi K; Kalgutkar AS
    Chem Res Toxicol; 2023 Jun; 36(6):934-946. PubMed ID: 37148271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic amine sulfonamides as linkers in the design and synthesis of novel human beta(3) adrenergic receptor agonists.
    Sum FW; Wong V; Han S; Largis E; Mulvey R; Tillett J
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2191-4. PubMed ID: 12798332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor.
    Kung DW; Coffey SB; Jones RM; Cabral S; Jiao W; Fichtner M; Carpino PA; Rose CR; Hank RF; Lopaze MG; Swartz R; Chen HT; Hendsch Z; Posner B; Wielis CF; Manning B; Dubins J; Stock IA; Varma S; Campbell M; DeBartola D; Kosa-Maines R; Steyn SJ; McClure KF
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4281-7. PubMed ID: 22677316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of a novel antiarrhythmic agent, bidisomide, in man: use of high resolution mass spectrometry to distinguish desisopropyl bidisomide from desacetyl bidisomide.
    Cook CS; Ames GB; Hribar JD; Liu NW; Sweeney DL; Schoenhard GL; Karim A
    Xenobiotica; 1995 Sep; 25(9):981-91. PubMed ID: 8553691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of Isosteres of Piperazine in the Design of Biologically Active Compounds: Part 2.
    Meanwell NA; Loiseleur O
    J Agric Food Chem; 2022 Sep; 70(36):10972-11004. PubMed ID: 35675052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
    Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
    J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-((Hetera)cyclobutyl)azetidines, "Stretched" Analogues of Piperidine, Piperazine, and Morpholine: Advanced Building Blocks for Drug Discovery.
    Feskov IO; Chernykh AV; Kuchkovska YO; Daniliuc CG; Kondratov IS; Grygorenko OO
    J Org Chem; 2019 Feb; 84(3):1363-1371. PubMed ID: 30583694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of azetidines and pyrrolidines via iodocyclisation of homoallyl amines and exploration of activity in a zebrafish embryo assay.
    Feula A; Dhillon SS; Byravan R; Sangha M; Ebanks R; Salih MA; Spencer N; Male L; Magyary I; Deng WP; Müller F; Fossey JS
    Org Biomol Chem; 2013 Aug; 11(31):5083-93. PubMed ID: 23824110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-tuned photochromic sulfonylureas for optical control of beta cell Ca
    Rückert AK; Ast J; Hasib A; Nasteska D; Viloria K; Broichhagen J; Hodson DJ
    Diabet Med; 2023 Dec; 40(12):e15220. PubMed ID: 37669696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Ring-Opening of N-Alkyl Pyrrolidines with Chloroformates to 4-Chlorobutyl Carbamates.
    Yu C; Shoaib MA; Iqbal N; Kim JS; Ha HJ; Cho EJ
    J Org Chem; 2017 Jul; 82(13):6615-6620. PubMed ID: 28593764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.
    Pettersson M; Campbell BM; Dounay AB; Gray DL; Xie L; O'Donnell CJ; Stratman NC; Zoski K; Drummond E; Bora G; Probert A; Whisman T
    Bioorg Med Chem Lett; 2011 Jan; 21(2):865-8. PubMed ID: 21185183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.
    Gray DL; Xu W; Campbell BM; Dounay AB; Barta N; Boroski S; Denny L; Evans L; Stratman N; Probert A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6604-7. PubMed ID: 19854053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesis.
    Smith EM; Sorota S; Kim HM; McKittrick BA; Nechuta TL; Bennett C; Knutson C; Burnett DA; Kieselgof J; Tan Z; Rindgen D; Bridal T; Zhou X; Jia YP; Dong Z; Mullins D; Zhang X; Priestley T; Correll CC; Tulshian D; Czarniecki M; Greenlee WJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4602-6. PubMed ID: 20580233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tantalum catalyzed hydroaminoalkylation for the synthesis of α- and β-substituted N-heterocycles.
    Payne PR; Garcia P; Eisenberger P; Yim JC; Schafer LL
    Org Lett; 2013 May; 15(9):2182-5. PubMed ID: 23600625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of 5HT3 and HT4 receptor expression in HT29 cell line and human colon adenocarcinoma tissues.
    Ataee R; Ajdary S; Rezayat M; Shokrgozar MA; Shahriari S; Zarrindast MR
    Arch Iran Med; 2010 Mar; 13(2):120-5. PubMed ID: 20187666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C
    J Med Chem; 1998 Dec; 41(25):5070-83. PubMed ID: 9836623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity.
    Kim N; Meyers KM; Mendez-Andino JL; Warshakoon NC; Ji W; Wos JA; Colson A; Mitchell MC; Davis JR; Pinney BB; Reizes O; Hu XE
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5445-50. PubMed ID: 16879961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.